Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Szyman Catherine M., Board Member. Officer active across 4 companies, notably Edwards Lifesciences Corp. Aggregated, 50 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €527k. History available since 4 May 2021. The latest transaction was filed on 11 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Szyman Catherine M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Szyman Catherine M. is a Board Member, with 50 filings in total. In the recent filings tracked, they cover the period from 2021-05-06 to 2026-03-16, with EUR 527054 of sales and a dominant transaction nature listed as Option exercise. They are linked to Edwards Lifesciences Corp, Inari Medical, Inc., Outset Medical, Inc. and MASIMO CORP.